Adverse Effects of Bone Marrow Stromal Cell Treatment of Stroke in Diabetic Rats | Zendy

Jieli Chen | Zendy; Xinchun Ye | Zendy; Tao Yan | Zendy; Chunling Zhang | Zendy; Xiao-Ping Yang | Zendy; Xu Cui | Zendy; Yishen Cui | Zendy; Alex Zacharek | Zendy; Cynthia J. Roberts | Zendy; Xinfeng Liu | Zendy; Xiangguo Dai | Zendy; Mei Lü | Zendy; Michael Chopp | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adverse Effects of Bone Marrow Stromal Cell Treatment of Stroke in Diabetic Rats

Author(s) -

Jieli Chen,

Xinchun Ye,

Tao Yan,

Chunling Zhang,

Xiao-Ping Yang,

Xu Cui,

Yishen Cui,

Alex Zacharek,

Cynthia J. Roberts,

Xinfeng Liu,

Xiangguo Dai,

Mei Lü,

Michael Chopp

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.111.627174

Subject(s) - medicine , stromal cell , bone marrow , stroke (engine) , adverse effect , diabetes mellitus , pathology , endocrinology , mechanical engineering , engineering

Cell therapy with bone marrow stromal cells (BMSCs) improves functional recovery after stroke in nondiabetic rats. However, its effect on diabetics with stroke is unknown. This study investigated the effect of BMSCs on stroke outcome in Type 1 diabetic (T1DM) rats.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research